ATOS Summary

  1. NASDAQ
  2. >
  3. ATOS
TickerATOS
DescriptionATOSSA THERAPEUTICS INC
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees5
Next Earnings DateAugust 12th, 2021
IV149.454181%
IV Percentile23rd
IV Rank17.47%
IV Skew-15.337924
IV Skew Percentile67th
IV Skew SentimentBearish
Option Volume31,599
Volume17,819,940
Price$3.2317
Previous Close$2.89
52-Week High$9.80
52-Week Low$0.81
50-Day Moving Avg.$5.31
200-Day Moving Avg.$3.41
10-Day Avg. Volume14,061,912
20-Day Avg. Volume18,029,147
30-Day Avg. Volume18,397,219
3-Month Avg. Volume21,398,531
EPS-$1.69
Outstanding Shares126,435,756
Market Capitalization$367,928,000
CurrencyUSD
UpdatedAugust 4th, 2021